Medicare is considering changes to an important program meant to provide beneficiaries with access to newly approved drugs and devices while collecting data on how they work in the real world. The nearly 20-year-old program, known as Coverage with Evidence Development (CED), has recently faced questions about whether it’s working as intended.
Join the USC Schaeffer Center for Health Policy & Economics, in partnership with the Tufts Center for Evaluation of Value and Risk in Health and the Stanford Mussallem Center for Biodesign, for a conversation on the future of CED at USC’s Capital Campus in Washington, D.C. Attendees will hear from Centers for Medicare and Medicaid Services (CMS) officials, learn about the latest research and share ideas on how CED could be improved.
Wednesday, September 25, 2024 8:30 AM - 12:00 PM Pacific
USC Capital Campus,
1st floor ballroom
1771 N Street NW
Washington, DC 20036
Panel
Welcome Remarks
Darius Lakdawalla, PhD
Chief Scientific Officer and Senior Scholar
USC Schaeffer
Fireside Chat
Tamara Syrek Jensen, JD
Director, Coverage & Analysis Group
Centers for Medicare & Medicaid Services
Barry Liden, JD
Director of Public Policy
USC Schaeffer
Review of Latest Perspectives
Darius Lakdawalla, PhD
USC Schaeffer
Joshua Makower, MD
Director
Stanford Mussallem Center for Biodesign
Peter Neumann, Sc.D
Director
Center for the Evaluation of Value and Risk in Health, Tufts Medical Center
Reactions: The Good, Bad and Ugly
Barry Liden, JD
USC Schaeffer
Gregory Daniel, PhD
Vice President, Global Public Policy
Eli Lilly and Company
John Dwyer, JD
Co-Founder and President
Global Alzheimer’s Platform Foundation
Perry Bridger, MHS
Senior Advisor, Public Affairs
Edwards Lifesciences
Robert McDonough
Senior Director for Clinical Policy Research and Development
Aetna
Closing Remarks
Darius Lakdawalla, PhD
USC Schaeffer